Randomised Controlled Trial of Intravitreal Triamcinolone in Patients with Diabetic Macular Oedema Refractory to Laser Treatment

ISRCTN ISRCTN90614292
DOI https://doi.org/10.1186/ISRCTN90614292
Protocol serial number N0192133909
Sponsor Department of Health
Funder Queen's Medical Centre University Hospital NHS Trust (UK)
Submission date
30/09/2004
Registration date
30/09/2004
Last edited
13/04/2011
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr S A Vernon
Scientific

B Floor
The Eye & ENT Unit
University Hospital
Nottingham
NG7 2UH
United Kingdom

Phone +44 (0)115 924 9924
Email stephen.vernon@nuh.nhs.uk

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study objectivesDoes principal intravitreal injection of triamcinolone help in treating diabetic patients with clinically significant macular oedema that is refractory to the conventional focal or grid laser photocoagulation?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedEye Diseases: Diabetic macular oedema
Intervention1. Intravitreal injection of tiamcinolone
2. Placebo

As of March 2008: trial abandoned due to poor recruitment.
Intervention typeDrug
PhaseNot Specified
Drug / device / biological / vaccine name(s)Triamcinolone
Primary outcome measure(s)

Pre-injection and then month 1, 3 and 6

1. Best corrected visual acuity (logarithm of the minimum angle of resolution [logMAR]) at each visit. A change in either direction of 10 letters on the logMAR chart would be considered significant
2. Near vision tested with a standard add on each visit, with time taken to read the standard N paragraph and the number of mistakes made
3. Intra-ocular pressure at each visit - measured by standard applanation tonometry

Key secondary outcome measure(s)

Not provided at time of registration

Completion date01/07/2006
Reason abandoned (if study stopped)Lack of staff/facilities/resources

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Key inclusion criteriaNot provided at time of registration
Key exclusion criteriaNot provided at time of registration
Date of first enrolment28/11/2003
Date of final enrolment01/07/2006

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

B Floor
Nottingham
NG7 2UH
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan